Latest News
NAVIGATOR Trial Outcomes for Tezepelumab Use in Severe, Uncontrolled Asthma
Noninvasive and Invasive Ventilation for Asthma Exacerbations in Children
Patients With Asthma Who Use Cannabis: Characteristics and Outcomes
A New Basis for Predicting Future COPD Exacerbations During the Pandemic
E-Cigarette Use Associated With Increased Odds of Asthma and COPD
Raised D-Dimer Linked to Mortality in Black Individuals With COVID-19 Pneumonia
Dupilumab Improves Severe Asthma Outcomes, Regardless of Baseline OCS Dose
Tezepelumab Improves Lung Function in Severe, Uncontrolled Asthma
Efficacy and Safety of Gefapixant for Refractory/Unexplained Chronic Cough
Nebulized Revefenacin for COPD Appears More Effective in Women vs Men
Inhaled Treprostinil and Lung Function in Patients With PH-ILD and PAH
Cyclophosphamide Not Recommended for Acute Exacerbation of Pulmonary Fibrosis
Adenovirus Pneumonia CT Patterns in Adults Who Are Immunocompromised
Cytokine Clusters and Immunity Profiles Associated With Disease Severity in Children With SARS-CoV-2 Infection
Latest Features
Guideline: Evidence-Based Best Practices for the Management of Cancer-Related Pain
The American Society of Pain and Neuroscience has published a best practice guideline for the management and reduction of cancer-associated pain.
Improving Black Representation in Oncology: ‘Be the Change’
Only 3% of medical oncologists in the United States are Black.
The Ongoing Challenge of Attracting and Retaining Health Care Providers
The pandemic has accelerated the number of clinicians retiring from practice.
How COVID-19 Affected Management of Lung Nodule Programs
Dramatic changes made to lung nodule programs due to COVID-19 included changes to screening criteria and follow-up protocols, plus a whole new group of patients.
Language in Patient Records Can Convey More Than Medical History
The language in a patient’s medical record can convey information not only about the patient’s condition but about the attitude of the clinician writing the report.
- Loading...
Loading...
Loading... 
Loading...